邮件订阅 RSS

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

医疗资源配置对脓毒症发生发展的影响及对策

王汉斌,  孙亚奇,  方向明

downloadPDF
文章导航 > 协和医学杂志  > 2017 >  8(6): 326-331
王汉斌, 孙亚奇, 方向明. 医疗资源配置对脓毒症发生发展的影响及对策[J]. 协和医学杂志, 2017, 8(6): 326-331. doi: 10.3969/j.issn.1674-9081.2017.06.002
引用本文: 王汉斌, 孙亚奇, 方向明. 医疗资源配置对脓毒症发生发展的影响及对策[J]. 协和医学杂志, 2017, 8(6): 326-331. doi: 10.3969/j.issn.1674-9081.2017.06.002
shu
Han-bin WANG, Ya-qi SUN, Xiang-ming FANG. Influence and Countermeasures of Medical Resource Allocation on the Occurrence and Development of Sepsis[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(6): 326-331. doi: 10.3969/j.issn.1674-9081.2017.06.002
Citation: Han-bin WANG, Ya-qi SUN, Xiang-ming FANG. Influence and Countermeasures of Medical Resource Allocation on the Occurrence and Development of Sepsis[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(6): 326-331. doi: 10.3969/j.issn.1674-9081.2017.06.002
shu

医疗资源配置对脓毒症发生发展的影响及对策

doi: 10.3969/j.issn.1674-9081.2017.06.002

  • 浙江大学医学院附属第一医院麻醉科, 杭州 310003

详细信息
    通讯作者:

    方向明 电话:0571-88208006, E-mail:xiangming_fang@163.com

  • 中图分类号: R631;R459.7

Influence and Countermeasures of Medical Resource Allocation on the Occurrence and Development of Sepsis

  • Department of Anesthesiology, First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China

More Information

    摘要
  • 摘要: 脓毒症是机体感染后出现的炎症、免疫等异常反应, 可导致严重的组织器官功能受损, 是目前临床常见且棘手的危重症之一。随着对因、对症集束治疗策略的不断完善, 脓毒症病死率有所下降; 但因人口老龄化、生活方式改变、各种并存慢性病发病率升高, 脓毒症的发病率也显著上升且病理过程更加复杂化, 每年总死亡人数明显增加。目前, 脓毒症已成为全球沉重的医疗负担, 这一问题在医疗资源配置落后地区尤为突出。本文将阐述医疗资源配置对脓毒症流行病学、医务人员监测诊治水平和医院管理成本等方面的影响, 进而就如何降低医疗资源配置落后对脓毒症发生发展的不良影响, 以及如何提高"拯救脓毒症运动"指南的依从性提出相应对策。
    Abstract: Sepsis is life-threatening multi-organ dysfunction caused by a dysregulated host response to infections, and it is one of the most common and thorny diseases in critically ill patients. With the complement and refinement of sepsis bundles, the mortality rate of sepsis has decreased. However, due to population aging, lifestyle changes, and increasing prevalence of coexisting chronic diseases, its incidence increases significantly, and the pathological process is more complicated, causing the number of annual deaths to rise. Sepsis has become a heavy global burden, which is particularly obvious in poorly resourced settings. The effects of health resource allocation on the epidemic of sepsis, the level of the diagnosis and treatment, and costs of care in sepsis will be discussed in this article. Moreover, it put forward proposals on how to reduce negative effects of poor resource on the occurrence and development of sepsis, and improve compliance of Surviving Sepsis Campaign guidelines.
    • HTML全文
    • 参考文献(56)
  • [1] Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315:801-810. doi:  10.1001/jama.2016.0287
    [2] SepNet Critical Care Trials Group. Incidence of severe sepsis and septic shock in German intensive care units:the prospective, multicentre INSEP study[J]. Intensive Care Med, 2016, 42:1980-1989. doi:  10.1007/s00134-016-4504-3
    [3] Novosad SA, Sapiano MR, Grigg C, et al. Epidemiology of sepsis:prevalence of health care factors and opportunities for prevention[J]. MMWR Morb Mortal Wkly Rep, 2016, 65:864-869. doi:  10.15585/mmwr.mm6533e1
    [4] Angus DC, van der Poll T. Severe sepsis and septic shock[J]. N Engl J Med, 2013, 369:840-851. doi:  10.1056/NEJMra1208623
    [5] Adhikari NK, Fowler RA, Bhagwanjee S, et al. Critical care and the global burden of critical illness in adults[J]. Lancet, 2010, 376:1339-1346. doi:  10.1016/S0140-6736(10)60446-1
    [6] Gupta RG, Hartigan SM, Kashiouris MG, et al. Early goal-directed resuscitation of patients with septic shock:current evidence and future directions[J]. Crit Care, 2015, 19:1-10. http://cn.bing.com/academic/profile?id=9ed1b010b8979b6dac339193f3861953&encoded=0&v=paper_preview&mkt=zh-cn
    [7] Stevenson EK, Rubenstein AR, Radin GT, et al. Two decades of mortality trends among patients with severe sepsis:a comparative meta-analysis[J]. Crit Care Med, 2014, 42:625-631. doi:  10.1097/CCM.0000000000000026
    [8] Miller RR 3rd, Dong L, Nelson NC, et al. Multicenter implementation of a severe sepsis and septic shock treatment bundle[J]. Am J Respir Crit Care Med, 2013, 188:77-82. http://cn.bing.com/academic/profile?id=37bb4cfde114c9207d62ddcb27d6eb08&encoded=0&v=paper_preview&mkt=zh-cn
    [9] Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign:association between performance metrics and outcomes in a 7.5-year study[J]. Crit Care Med, 2015, 43:3-12. http://cn.bing.com/academic/profile?id=f8912cd1fb68ac695c516473acf028c3&encoded=0&v=paper_preview&mkt=zh-cn
    [10] Rhodes A, Phillips G, Beale R, et al. The Surviving Sepsis Campaign bundles and outcome:results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study)[J]. Intensive Care Med, 2015, 41:1620-1628. doi:  10.1007/s00134-015-3906-y
    [11] Phua J, Koh Y, Du B, et al. Management of severe sepsis in patients admitted to Asian intensive care units:prospective cohort study[J].BMJ, 2011, 342:d3245. http://cn.bing.com/academic/profile?id=442c2ab0602be55b44b45b3882e285e2&encoded=0&v=paper_preview&mkt=zh-cn
    [12] Zhou J, Qian C, Zhao M, et al. Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China[J]. PLoS One, 2014, 9:e107181. doi:  10.1371/journal.pone.0107181
    [13] Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012[J]. JAMA, 2014, 311:1308-1316. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=22c72f0be93fe0027faf0e68bed835d6
    [14] Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000[J]. N Engl J Med, 2003, 348:1546-1554. doi:  10.1056/NEJMoa022139
    [15] Walkey AJ, Lagu T, Lindenauer PK. Trends in sepsis and infection sources in the United States. A population-based study[J]. Ann Am Thorac Soc, 2015, 12:216-220. doi:  10.1513/AnnalsATS.201411-498BC
    [16] Yébenes JC, Ruiz-Rodriguez JC, Ferrer R, et al. Epide-miology of sepsis in Catalonia:analysis of incidence and outcomes in a European setting[J]. Ann Intensive Care, 2017, 7:19. http://www.ncbi.nlm.nih.gov/pubmed/28220453
    [17] Cheng AC, West TE, Limmathurotsakul D, et al. Strategies to reduce mortality from bacterial sepsis in adults in developing countries[J]. PLoS Med, 2008, 5:e175. doi:  10.1371/journal.pmed.0050175
    [18] Fleischmann C, Scherag A, Adhikari NK, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations[J]. Am J Respir Crit Care Med, 2016, 19:259-272. http://cn.bing.com/academic/profile?id=0e359def98fb8856671b1c0df7b26ee5&encoded=0&v=paper_preview&mkt=zh-cn
    [19] Cheng B, Xie G, Yao S, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China[J]. Crit Care Med, 2007, 35:2538-2546. http://cn.bing.com/academic/profile?id=2e072733589612c26fb700355fdbdc7b&encoded=0&v=paper_preview&mkt=zh-cn
    [20] Kauss IA, Grion CM, Cardoso LT, et al. The epidemiology of sepsis in a Brazilian teaching hospital[J]. Braz J Infect Dis, 2010, 14:264-270. doi:  10.1016/S1413-8670(10)70054-4
    [21] Zhou J, Tian H, Du X, et al. Population-based epidemiology of sepsis in a subdistrict of Beijing[J]. Crit Care Med, 2017, 45:1168-1176. doi:  10.1097/CCM.0000000000002414
    [22] Brun-Buisson C, Meshaka P, Pinton P, et al. EPISEPSIS:a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units[J]. Intensive Care Med, 2004, 30:580-588. doi:  10.1007/s00134-003-2121-4
    [23] Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units[J]. JAMA, 2009, 302:2323-2329. doi:  10.1001/jama.2009.1754
    [24] GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015:a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet, 2016, 388:1459-1544. doi:  10.1016/S0140-6736(16)31012-1
    [25] Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2015, 386:743-800. doi:  10.1016/S0140-6736(15)60692-4
    [26] Laxminarayan R, Sridhar D, Blaser M, et al. Achieving global targets for antimicrobial resistance[J]. Science, 2016, 353:874-875. doi:  10.1126/science.aaf9286
    [27] Matthiessen L, Bergström R, Dustdar S, et al. Increased momentum in antimicrobial resistance research[J]. Lancet, 2016, 388:865. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=1dc0bb182ec2e43ab03a3318cd52a5de
    [28] Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-the need for global solutions[J]. Lancet Infect Dis, 2013, 13:1057-1098. doi:  10.1016/S1473-3099(13)70318-9
    [29] Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials:a worldwide challenge[J].Lancet, 2016, 387:168-175. doi:  10.1016/S0140-6736(15)00474-2
    [30] WHO.Antimicrobial Resistance: Global Report on Surveillance 2014[R/OL].[2014-05-05].http://www.who.int/drugresistance/documents/surveillancereport/en/.
    [31] Van Boeckel TP, Gandra S, Ashok A, et al.Global antibiotic consumption 2000 to 2010:an analysis of national pharmaceutical sales data[J]. Lancet Infect Dis, 2014, 14:742-750. doi:  10.1016/S1473-3099(14)70780-7
    [32] Judson JA, Fisher MM. Intensive care in Australia and New Zealand[J]. Crit Care Clin, 2006, 22:407-423, vii-viii. doi:  10.1016/j.ccc.2006.03.012
    [33] Rhodes A, Ferdinande P, Flaatten H, et al. The variability of critical care bed numbers in Europe[J]. Intensive Care Med, 2012, 38:1647-1653. doi:  10.1007/s00134-012-2627-8
    [34] Wunsch H, Angus DC, Harrison DA, et al. Variation in critical care services across North America and Western Europe[J]. Crit Care Med, 2008, 36:2787-2793, e1-e9. doi:  10.1097/CCM.0b013e318186aec8
    [35] Haniffa R, De Silva AP, Iddagoda S, et al. A cross-sectional survey of critical care services in Sri Lanka:a lower middle-income country[J]. J Crit Care, 2014, 29:764-768. doi:  10.1016/j.jcrc.2014.04.021
    [36] Du B, Xi X, Chen D, et al. Clinical review:critical care medicine in mainland China[J]. Crit Care, 2010, 14:206. doi:  10.1186/cc8222
    [37] Bhagwanjee S, Scribante J. National audit of critical care resources in South Africa-unit and bed distribution[J]. S Afr Med J, 2007, 97:1311-1314. http://cn.bing.com/academic/profile?id=235ba58eae84c295772476de39385778&encoded=0&v=paper_preview&mkt=zh-cn
    [38] Jochberger S, Ismailova F, Lederer W, et al. Anesthesia and its allied disciplines in the developing world:a nationwide survey of the Republic of Zambia[J]. Anesth Analg, 2008, 106:942-948. doi:  10.1213/ane.0b013e318166ecb8
    [39] Kwizera A, Dünser M, Nakibuuka J. National intensive care unit bed capacity and ICU patient characteristics in a low income country[J]. BMC Res Notes, 2012, 5:475. doi:  10.1186/1756-0500-5-475
    [40] Schultz MJ, Dunser MW, Dondorp AM, et al. Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future[J]. Intensive Care Med, 2017, 43:612-624. doi:  10.1007/s00134-017-4750-z
    [41] Kwizera A, Festic E, Dünser MW. What's new in sepsis recognition in resource-limited settings?[J]. Intensive Care Med, 2016, 42:2030-2033. doi:  10.1007/s00134-016-4222-x
    [42] Lagu T, Rothberg MB, Shieh MS, et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007[J]. Crit Care Med, 2012, 40:754-761. doi:  10.1097/CCM.0b013e318232db65
    [43] Champunot R, Thawitsri T, Kamsawang N, et al. Cost effectiveness analysis of an initial ICU admission as compared to a delayed ICU admission in patients with severe sepsis or in septic shock[J]. J Med Assoc Thai, 2014, 97:S102-S107. http://cn.bing.com/academic/profile?id=f85b79bdc2b876a65aa75547cb467f83&encoded=0&v=paper_preview&mkt=zh-cn
    [44] Talmor D, Greenberg D, Howell MD, et al. The costs and cost-effectiveness of an integrated sepsis treatment protocol[J]. Crit Care Med, 2008, 36:1168-1174. doi:  10.1097/CCM.0b013e318168f649
    [45] Suarez D, Ferrer R, Artigas A, et al. Cost-effectiveness of the Surviving Sepsis Campaign protocol for severe sepsis:a prospective nation-wide study in Spain[J]. Intensive Care Med, 2011, 37:444-452. doi:  10.1007/s00134-010-2102-3
    [46] Negrini D, Sheppard L, Mills GH, et al. International Programme for Resource Use in Critical Care (IPOC)-a methodology and initial results of cost and provision in four European countries[J]. Acta Anaesthesiol Scand, 2006, 50:72-79. doi:  10.1111/j.1399-6576.2006.00901.x
    [47] Tan SS, Bakker J, Hoogendoorn ME, et al. Direct cost analysis of intensive care unit stay in four European countries:applying a standardized costing methodology[J]. Value Health, 2012, 15:81-86. doi:  10.1016/j.jval.2011.09.007
    [48] Kulkarni AP, Divatia JV. A prospective audit of costs of intensive care in cancer patients in India[J]. Indian J Crit Care Med, 2013, 17:292-297. doi:  10.4103/0972-5229.120321
    [49] Dondorp AM, Iyer SS, Schultz MJ. Critical Care in Resource-Restricted Settings[J]. JAMA, 2016, 315:753-754. doi:  10.1001/jama.2016.0976
    [50] Haniffa R, Lubell Y, Cooper BS, et al. Impact of a structured ICU training programme in resource-limited settings in Asia[J]. PLoS One, 2017, 12:e0173483. doi:  10.1371/journal.pone.0173483
    [51] Schorr CA, Dellinger RP. The Surviving Sepsis Campaign:past, present and future[J]. Trends Mol Med, 2014, 20:192-194. doi:  10.1016/j.molmed.2014.02.001
    [52] 谭珂, 潘新华, 高原.医学虚拟仿真教学环境的构建[J].中国医学教育技术, 2012, 26:535-538. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyxjyjs201205015
    [53] Yee B, Naik VN, Joo HS, et al. Nontechnical skills in anesthesia crisis management with repeated exposure to simulation-based education[J]. Anesthesiology, 2005, 103:241-248. doi:  10.1097/00000542-200508000-00006
    [54] Lorello GR, Cook DA, Johnson RL, et al. Simulation-based training in anaesthesiology:a systematic review and meta-analysis[J]. Br J Anaesth, 2014, 112:231-245. doi:  10.1093/bja/aet414
    [55] Kennedy CC, Cannon EK, Warner DO, et al. Advanced airway management simulation training in medical education:a systematic review and meta-analysis[J]. Crit Care Med, 2014, 42:169-178. doi:  10.1097/CCM.0b013e31829a721f
    [56] Cui P, Fang X. Pathogenesis of infection in surgical patients[J]. Curr Opin Crit Care, 2015, 21:343-350. doi:  10.1097/MCC.0000000000000227
    • 相关文章
    • 施引文献
  • 资源附件(0)
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  244
  • HTML全文浏览量:  31
  • PDF下载量:  92
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-08-21
  • 刊出日期:  2017-11-30

目录

    /

    返回文章
    返回
    友情链接: 国家卫生健康委员会 北京协和医院 中国医学科学院 学术不端检测系统 国际知识资源总库 中国知网 术语在线 中国全科医学
    地址：北京市东城区帅府园1号 北京协和医院老楼7号楼
    3层302室 《协和医学杂志》编辑部
    电话：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    期刊网站版权所有：《协和医学杂志》编辑部
    京ICP备 11002662

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计

    x 关闭 永久关闭

    【温馨提醒】近日，《协和医学杂志》编辑部接到作者反映，有多名不法人员冒充期刊编辑发送见刊通知，鼓动作者添加微信，从而骗取版面费的行为。特提醒您，本刊与作者联系的方式均为邮件通知或电话，稿件进度通知邮箱为：mjpumch@126.com，编辑部电话为：010-69154261，请提高警惕，谨防上当受骗！如有任何疑问，请致电编辑部核实。谢谢！